TNFSF10 and amyloidosis: Given the concurrent immunological changes and neuropathology observed in 3xTg-AD mice (Marchese et al. 2014), we investigated whether administering anti-TNFSF10 mAb at a late stage of pathology could modulate amyloidosis in both the hippocampus and spleen of these mice.